LIVA-HEALTHCARE
13.5.2020 09:32:04 CEST | Business Wire | Press release
Liva Healthcare continues its UK growth plan with four new contracts as part of the Healthier You: NHS Diabetes Prevention Programme (NHS DPP). The NHS DPP is delivered by a group of providers including Liva and Living Well Taking Control (LWTC).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200513005029/en/
This follows Liva's announcement of 13 contract wins across healthcare providers, insurance and pharmaceutical organisations at the start of 2020. The company also secured an investment of €8 million from three venture funds in 2019.
The four clinical commissioning groups (CCGs) that will now have access to Liva’s diabetes prevention programme are; Derbyshire, Nottinghamshire, Northamptonshire, and Worcester and Hereford. CCGs in Dorset, Shropshire, Wrekin, and Telford have already been welcomed onto the programme.
Over the next three years, as part of the Healthier You: NHS Diabetes Prevention Programme, Liva will deliver personal health coaching to almost 11,000 patients who are at high risk of Type 2 diabetes. This is in addition to nearly 44,000 patients who will have access to Liva's app to supplement a face-to-face intervention programme led by LWTC.
Liva Healthcare is a Copenhagen and London based health tech company that provides patients with access to a dedicated health coach for professional guidance, support, and empathy. Regular coaching sessions help patients tackle chronic conditions through sustainable lifestyle and behaviour changes. The Liva programme has been proven to halt and reverse the progression of Type 2 diabetes.
Kristoffer From, CEO at Liva Healthcare, says: " This is an exciting achievement and demonstrates our commitment to the UK healthcare industry. Taking on these contracts proves how adaptable and scalable our proposition is. We are proud to be a partner to the Healthier You: NHS Diabetes Prevention Programme.
"The NHS is leading the charge in the global fight against diabetes. This programme is the largest of its kind and by incorporating digital and face-to-face interventions, the NHS is demonstrating its commitment to healthcare innovation.
“It is important that patients at high risk of developing Type 2 diabetes can access support beyond traditional in-person services. Anybody going through our programme will receive professional guidance, support, and empathy, to help tackle or prevent chronic conditions through sustainable lifestyle and behavior changes."
Liva will continue to invest in its established markets across Europe, Asia-Pacific and Canada while it expands into key European growth markets.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200513005029/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
Roboverse Reply Impresses at ELROB 2026 With Intelligent Robotic Systems for Critical Missions26.6.2026 10:00:00 CEST | Press release
Roboverse Reply, the Reply Group company specializing in robotics and automation, won the 1st Place in the “Reconnaissance” category and a special prize for “Best Team Effort” at the European Land Robot Trial (ELROB) 2026 in Thun, Switzerland. Teaming up with ELP, a specialist for technical equipment for defusing service, the company demonstrated outstanding performance alongside a field of international participants from June 15 to 19, proving that its autonomous solutions operate reliably under real-world conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626012237/en/ Roboverse Reply won 1st Place in the “Reconnaissance” category and a special prize for “Best Team Effort” at the European Land Robot Trial 2026, proving that its autonomous solutions operate reliably under real-world conditions. ELROB is Europe’s most demanding and established showcase for robotics and unmanned systems, where leading experts from
The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”26.6.2026 10:00:00 CEST | Press release
The ranking recognizes companies best positioned to thrive amid AI-driven and structural economic change Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute’s inaugural “Best Companies for the Future” ranking, which evaluates large corporations on their ability to adapt and succeed in a rapidly evolving global environment. PMI ranks at #97 overall and is the third highest ranked company in the Food Beverage & Tobacco industry group after Coca-Cola and PepsiCo. Compiled by Bendable Labs for the WSJ Leadership Institute, a premium executive learning and leadership program from Dow Jones and The Wall Street Journal, the ranking assesses companies across six key dimensions - AI readiness, innovation, talent readiness, financial fitness, resilience, and agility - to identify those that are best positioned for long-term success. PMI’s inclusion reflects the reality that today it is a leading international consumer goods company, focused on a smoke
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom